In addition, while diminishing FAP+ CAFs in mice has been shown to reduce tumor burden in melanoma and pancreatic cancer models, associated with impaired immunosuppressive functions and reduced angiogenesis, respectively [295,316,317], it has also been shown to cause adverse side effects such as cachexia and anemia in a transgenic mouse model [318]. This evidence concerns the gene FAP and neoplasm.